74 IdiotrophおよびCeruleninを利用するTylosinおよび関連化合物の生合成研究
スポンサーリンク
概要
- 論文の詳細を見る
We have obtained a mutant strain No. 261 by the treatment of the tylosin (1) producing strain, Streptomyces fradiae KA-427, with nitrosoguanidine. The structures of protylonolide (3) and mycarosyl protylonolide (4) isolated from the culture broth of the mutant were elucidated by mass and nmr spectrometry and X-ray crystallography. The absolute configuration of 1 was deduced from the evidence that 3 is bioconverted to 1 and spectral identity of 1, 3 and leucomycin A_3 in which the absolute configuration was already established. Cofermentation and bioconversion studies indicated that mutant No. 261 is an idiotroph of mycaminose. Hybrid biosynthesis of tylosin-related compound was attempted using an antibiotic producer and cerulenin, an inhibitor of polyketide biosynthesis. The feeding of 3 to the fermentation broth of Streptomyces sp. AM-4900 producing picromycin, a 14-membered macrolide antibiotic, gave a product designated as 5-O-desosaminyl protylonolide (9) (=M-4365 G_1, 6). Consequently, it was found that the absolute configuration of M-4365 G_<1-3> (6, 7, 8) are identical with that of 1. Furthermore, in order to clarify the biosynthetic pathway after the lactone ring formation of 1, we attempted the syntheses of many tylosin-related compounds and examined the ability for the bioconversion of these compounds to 1 by Sm. fradiae in the presence of cerulenin. As a result, the preferred pathway from 3 to 1 are as follows: 1) addition of mycaminose to C_5-OH of 3; 2) oxidation of C_<20>-methyl to aldehyde and C_<23>-methyl to alcohol in undetermined order; 3) addition of mycinose to C_<23>-OH; 4) addition of mycarose to C_4'-OH. The biosynthetic relation of 1 and relomycin (2) is also discussed.
- 天然有機化合物討論会の論文
- 1980-09-10
著者
-
中川 彰
帝京大理工
-
大村 智
北里大薬
-
大村 智
北里研究所生物機能研究所
-
松原 肇
School Of Pharmaceutical Sciences Kitasato University And The Kitasato Institute
-
定金 典明
School of Pharmaceutical Sciences, Kitasato University and The Kitasato Institute
-
喜多尾 千秋
北里大薬
-
定金 典明
北里大薬
-
松原 肇
北里大薬
-
中川 彰
北里研
-
喜多尾 千秋
Kitasato University and The Kitasato Institute
-
大村 智
北里大薬:北里研
-
定金 典明
School Of Pharmaceutical Sciences Kitasato University And The Kitasato Institute
関連論文
- Bioconversion and Biosynthesis of 16-Membered Macrolide Antibiotics. X. Final Steps in the Biosynthesis of Spiramycin, using Enzyme Inhibitor : Cerulenin
- 98 放線菌の生産する神経突起伸長作用物質ラクタシスチンの生合成研究(ポスター発表の部)
- Bioconversion and Biosynthesis of 16-Membered Macrolide Antibiotics. XXII. Biosynthesis of Tylosin after Protylonolide Formation
- Chemical Transformation of Tylosin, a 16-Membered Macrolide, and Its Structure-Activity Relationship
- 74 IdiotrophおよびCeruleninを利用するTylosinおよび関連化合物の生合成研究
- Isolation and Characterization of a New 16-Membered Lactone, Protylonolide, from a Mutant of Tylosin-Producing Strain, Streptomyces fradiae KA-427
- 抗HIV活性を有するgp120-CD4結合阻害剤
- 32 生合成的手段を利用した抗コクシジウム抗生物質Xanthoquinodin類の構造研究(口頭発表の部)
- 40 新奇なポリケチド抗生物質フトラマイシン及びオキラクトマイシンの構造と生合成(口頭発表の部)
- 抗生物質--生合成手段を用いる構造決定と新規物質の創製 (動的天然物化学)
- Effects of Phytosterols on Anti-complementary Activity(Pharmacognosy,Chemical)
- 37 新規抗菌抗生物質Aurantininの生合成的手段による構造決定(口頭発表の部)
- 10 放線菌由来の新規大環状ラクタム抗生物質の構造
- 新しい生理活性を有するマクロライド抗生物質
- Herbimycin Bの構造 (生物活性物質)
- 54 Asukamycinの化学構造
- 53 Herbimycin及びElasninの構造^C-nmrを用いる生合成的手段の併用
- Structure of a New Antimicrobial Unsaturated Fatty Acid from Sm. kitasatoensis NU-23-1
- Chemistry of Leucomycins. XII. Application of the Modified Polonovski Reaction to Leucomycin-A_3 N-Oxide
- 57 ^C-NMRによる16員環macrolide抗生物質の生合成研究
- Alternaria alternata群病原菌における宿主特異的毒素生成の制御 : (2) 化学物質による毒素生成の阻害
- 発酵と合成の有機的結合-chemical modificationの将来性-続-16員環Macrolide抗生物質の化学修飾 (微生物の生産物と医療-5-)
- 75 セトミマイシンの構造と生合成
- 31 ロイコマイシンの化学XI : LeucomycinのAglyconeの単離,mycaminose上の化学的修飾及び16員環macrolide抗生物質の構造と活性
- 59(P-35) 放線菌由来の新規ICAM-1/LFA-1依存性細胞接着阻害物質、Adxanthromycinに関する研究(ポスター発表の部)
- Chemistry of Leucomycins. XI. Chemical Transformation of a Basic Macrolide to a Neutral Macrolide
- Structures and Biological Properties of Kinamycin A, B, C, and D
- Structure of Kinamycin C, and the Structural Relationship among Kinamycin A, B, C, and D
- Chemistry of Leucomycins. VIII. Absolute Configuration of Leucomycin and Isoleucomycin
- アルギン酸分解酵素生産菌の探索と酵素の精製 : 微生物
- (43) Alternaria alternata 群病原菌における宿主特異的毒素生成の制御 : (2) 毒素生成に対するセルレニンの阻害効果 (関西部会講演要旨)
- 新しい抗生物質を求めて
- マクロライド抗生物質の生合成 (微生物の生産物と医療-3-抗生物質の発酵生産と生合成) -- (生合成と代謝制御)
- くすりにならなかった抗生物質 : セルレニン
- 抗生物質-生合成手段を用いる構造決定と新規物質の創製